Literature DB >> 21795595

Cutting Edge: Regulator of G protein signaling-1 selectively regulates gut T cell trafficking and colitic potential.

Deena L Gibbons1, Lucie Abeler-Dörner, Tim Raine, Il-Young Hwang, Anett Jandke, Melanie Wencker, Livija Deban, Christopher E Rudd, Peter M Irving, John H Kehrl, Adrian C Hayday.   

Abstract

The RGS1 gene is associated with celiac disease, multiple sclerosis, and type I diabetes, which are all T cell-mediated pathologies, yet there is no reported analysis of regulator of G protein signaling (RGS)1 biology in human T cells. This study shows that RGS1 expression is substantially higher in T cells from human gut versus peripheral blood and that this can be exaggerated in intestinal inflammation. Elevated RGS1 levels profoundly reduce T cell migration to lymphoid-homing chemokines, whereas RGS1 depletion selectively enhances such chemotaxis in gut T cells and impairs their colitogenic potential. These findings provide a revised framework in which to view the linkage of RGS1 to inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21795595      PMCID: PMC3166702          DOI: 10.4049/jimmunol.1100833

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Regulator of G protein signaling 1 (RGS1) markedly impairs Gi alpha signaling responses of B lymphocytes.

Authors:  C Moratz; V H Kang; K M Druey; C S Shi; A Scheschonka; P M Murphy; T Kozasa; J H Kehrl
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

2.  Abnormal B-cell responses to chemokines, disturbed plasma cell localization, and distorted immune tissue architecture in Rgs1-/- mice.

Authors:  Chantal Moratz; J Russell Hayman; Hua Gu; John H Kehrl
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  Isolation of functionally active intraepithelial lymphocytes and enterocytes from human small and large intestine.

Authors:  C Lundqvist; M L Hammarström; L Athlin; S Hammarström
Journal:  J Immunol Methods       Date:  1992-08-10       Impact factor: 2.303

4.  Ulcerative colitis and adenocarcinoma of the colon in G alpha i2-deficient mice.

Authors:  U Rudolph; M J Finegold; S S Rich; G R Harriman; Y Srinivasan; P Brabet; G Boulay; A Bradley; L Birnbaumer
Journal:  Nat Genet       Date:  1995-06       Impact factor: 38.330

5.  Rgs1 and Gnai2 regulate the entrance of B lymphocytes into lymph nodes and B cell motility within lymph node follicles.

Authors:  Sang-Bae Han; Chantal Moratz; Ning-Na Huang; Brian Kelsall; Hyeseon Cho; Chong-Shan Shi; Owen Schwartz; John H Kehrl
Journal:  Immunity       Date:  2005-03       Impact factor: 31.745

6.  RGS2/G0S8 is a selective inhibitor of Gqalpha function.

Authors:  S P Heximer; N Watson; M E Linder; K J Blumer; J R Hepler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

7.  Follicular dendritic cell regulation of CXCR4-mediated germinal center CD4 T cell migration.

Authors:  Jacob D Estes; Tyler C Thacker; Denise L Hampton; Sariah A Kell; Brandon F Keele; Emily A Palenske; Kirk M Druey; Gregory F Burton
Journal:  J Immunol       Date:  2004-11-15       Impact factor: 5.422

8.  Role of regulator of G protein signaling 16 in inflammation-induced T lymphocyte migration and activation.

Authors:  Eric Lippert; David L Yowe; Jose-Angel Gonzalo; J Paul Justice; Jeremy M Webster; Eric R Fedyk; Martin Hodge; Cheryl Miller; Jose-Carlos Gutierrez-Ramos; Francisco Borrego; Andrea Keane-Myers; Kirk M Druey
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

9.  Inhibition of Th1 responses prevents inflammatory bowel disease in scid mice reconstituted with CD45RBhi CD4+ T cells.

Authors:  F Powrie; M W Leach; S Mauze; S Menon; L B Caddle; R L Coffman
Journal:  Immunity       Date:  1994-10       Impact factor: 31.745

10.  Interleukin-23 drives intestinal inflammation through direct activity on T cells.

Authors:  Philip P Ahern; Chris Schiering; Sofia Buonocore; Mandy J McGeachy; Dan J Cua; Kevin J Maloy; Fiona Powrie
Journal:  Immunity       Date:  2010-08-27       Impact factor: 31.745

View more
  34 in total

1.  RGS3 controls T lymphocyte migration in a model of Th2-mediated airway inflammation.

Authors:  Jesse W Williams; Douglas Yau; Nan Sethakorn; Jacob Kach; Eleanor B Reed; Tamson V Moore; Judy Cannon; Xiaohua Jin; Heming Xing; Anthony J Muslin; Anne I Sperling; Nickolai O Dulin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-27       Impact factor: 5.464

Review 2.  Therapeutic approaches for celiac disease.

Authors:  Nicholas M Plugis; Chaitan Khosla
Journal:  Best Pract Res Clin Gastroenterol       Date:  2015-05-09       Impact factor: 3.043

3.  Regulator of G-protein Signaling (RGS)1 and RGS10 Proteins as Potential Drug Targets for Neuroinflammatory and Neurodegenerative Diseases.

Authors:  Jae-Kyung Lee; Josephine Bou Dagher
Journal:  AAPS J       Date:  2016-02-22       Impact factor: 4.009

4.  Regulated genes in mesenchymal stem cells and gastric cancer.

Authors:  Shihori Tanabe; Kazuhiko Aoyagi; Hiroshi Yokozaki; Hiroki Sasaki
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

5.  Molecular profiling of CD8 T cells in autochthonous melanoma identifies Maf as driver of exhaustion.

Authors:  Marilyn Giordano; Coralie Henin; Julien Maurizio; Claire Imbratta; Pierre Bourdely; Michel Buferne; Lukas Baitsch; Laurent Vanhille; Michael H Sieweke; Daniel E Speiser; Nathalie Auphan-Anezin; Anne-Marie Schmitt-Verhulst; Grégory Verdeil
Journal:  EMBO J       Date:  2015-07-02       Impact factor: 11.598

Review 6.  Genetic Analysis of Rare Human Variants of Regulators of G Protein Signaling Proteins and Their Role in Human Physiology and Disease.

Authors:  Katherine E Squires; Carolina Montañez-Miranda; Rushika R Pandya; Matthew P Torres; John R Hepler
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

7.  Normal Thymocyte Egress, T Cell Trafficking, and CD4+ T Cell Homeostasis Require Interactions between RGS Proteins and Gαi2.

Authors:  Il-Young Hwang; Chung Park; Kathleen Harrison; John H Kehrl
Journal:  J Immunol       Date:  2017-02-24       Impact factor: 5.422

Review 8.  R4 Regulator of G Protein Signaling (RGS) Proteins in Inflammation and Immunity.

Authors:  Zhihui Xie; Eunice C Chan; Kirk M Druey
Journal:  AAPS J       Date:  2015-11-23       Impact factor: 4.009

Review 9.  RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives.

Authors:  Maciej Salaga; Martin Storr; Kirill A Martemyanov; Jakub Fichna
Journal:  Bioessays       Date:  2016-01-28       Impact factor: 4.345

Review 10.  The impact of RGS and other G-protein regulatory proteins on Gαi-mediated signaling in immunity.

Authors:  John H Kehrl
Journal:  Biochem Pharmacol       Date:  2016-04-09       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.